---
title: "Avantor | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 1.692 B"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294189086.md"
datetime: "2026-07-29T10:15:53.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294189086.md)
  - [en](https://longbridge.com/en/news/294189086.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294189086.md)
generator: "portal-rs"
---

# Avantor | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 1.692 B

Revenue: As of FY2026 Q2, the actual value is USD 1.692 B, beating the estimate of USD 1.611 B.

EPS: As of FY2026 Q2, the actual value is USD 0.06, missing the estimate of USD 0.085.

EBIT: As of FY2026 Q2, the actual value is USD 161.2 M.

#### Overall Performance

Avantor, Inc. reported net sales of $1,692.3 million for the three months ended June 30, 2026, representing a 0.5% increase compared to the second quarter of 2025; however, organic net sales declined by 0.4%. Net income decreased to $38.1 million from $64.7 million in the prior-year period, resulting in a net income margin of 2.3%. Adjusted EBITDA was $254.3 million, with an adjusted EBITDA margin of 15.0%. Operating income stood at $121.8 million, with an operating income margin of 7.2%, while adjusted operating income was $225.1 million, achieving an adjusted operating income margin of 13.3%.

#### Segment Revenue

-   **VWR Distribution & Services:** Net sales for this segment were $1,240.5 million, a reported increase of 2.7% from $1,207.5 million in the second quarter of 2025, with organic sales increasing by 1.7%.
-   **Bioscience & Medtech Products:** This segment recorded net sales of $451.8 million, a reported decrease of 5.1% from $475.9 million in the second quarter of 2025, and organically, sales declined by 5.6%.

#### Segment Operating Income

-   **VWR Distribution & Services:** Adjusted Operating Income for the segment was $126.4 million, compared to $141.6 million in the comparable prior period, with an Adjusted Operating Income margin of 10.2%.
-   **Bioscience & Medtech Products:** Adjusted Operating Income was $117.6 million, compared to $131.4 million in the comparable prior period, with an Adjusted Operating Income margin of 26.0%.

#### Cash Flow and Balance Sheet

Operating cash flow for the three months ended June 30, 2026, was $178.2 million, an increase from $154.4 million in the second quarter of 2025. Free cash flow was $142.8 million, up from $125.4 million in the same period last year. Avantor, Inc. repaid $112.1 million of debt during the quarter. As of June 30, 2026, total gross debt was $3,715.4 million, and cash and cash equivalents totaled $306.8 million. GAAP net leverage was -5.9x, and adjusted net leverage was 3.3x as of the same date.

#### Fiscal Year 2026 Guidance

Avantor, Inc. has updated its fiscal 2026 financial guidance, increasing its organic revenue growth outlook to -0.5% to +0.5% from the previous range of -2.5% to -0.5%. The company also raised its adjusted EPS guidance to $0.80 to $0.83, up from $0.77 to $0.83 previously. The guidance for Adjusted EBITDA margin remains at 14.8% to 15.3%, and free cash flow guidance is maintained at $500 million to $550 million.

### Related Stocks

- [AVTR.US](https://longbridge.com/en/quote/AVTR.US.md)

## Related News & Research

- [Avantor amends filing to set executive Benoit Gourdier departure for Oct. 14, 2026](https://longbridge.com/en/news/297232004.md)
- [MMED: Q1 FY27 delivered 17% net sales growth and raised full-year organic revenue guidance to 10.5%](https://longbridge.com/en/news/297640006.md)
- [16:49 ETPRIM Deadline: PRIM Investors with Losses in Excess of $100K Have Opportunity to Lead Primoris Services Corporation Securities Fraud Lawsuit](https://longbridge.com/en/news/297560782.md)
- [MDT: Q1 FY27 saw 13.7% organic revenue growth and raised FY27 guidance on broad-based strength](https://longbridge.com/en/news/297639606.md)
- [21:25 ETRXT Investors Have Opportunity to Lead Rackspace Technology, Inc. Securities Fraud Lawsuit](https://longbridge.com/en/news/297579136.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**